Beam Therapeutics: sellers regain control
Beam Therapeutics drops 6.1%: sellers in control, money flow turns negative
Beam Therapeutics: sellers regain control
Our view last week
Beam Therapeutics is in week 11 of a buy signal, up 10.83% since entry. All 3 targets of our most advanced model have already been hit: coverage is complete, and the remaining share of the position continues with a trailing stop on the Inversion Point. The setup quality indicator sits at 68 out of 100, in a maturity squeeze, with a medium signal strength of 66 out of 100.
This week's summary
Beam Therapeutics stock drops 6.1% in a week ruled by sellers, with only 19% of volume on the buy side and money flow turning negative after weeks of accumulation. The weekly technical analysis, though, does not retreat: the ADX climbs to 34.5, the trend gaining conviction. The gain since entry stays positive, now down to 4.1%.
IQS Phase
37
ordinary
Signal Strength
70
high · wide & volatile
Sizing
FULL
Ranking
#56 / 129
US stocks in progress
Trade P&L %
+4.11%
from signal to today
restricted Platinum content